Page last updated: 2024-10-30

2-mercaptoethylguanidine and Leukemia

2-mercaptoethylguanidine has been researched along with Leukemia in 1 studies

2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
AMBRUS, JL1
AMBRUS, CM1
PICKREN, JW1
FELTZ, E1
BACK, N1

Other Studies

1 other study available for 2-mercaptoethylguanidine and Leukemia

ArticleYear
SELECTIVE PROTECTION OF THE GASTROINTESTINAL TRACT AGAINST RADIATION INJURY BY PERFUSION WITH MEG (2-MERCAPTOETHYLGUANIDINE HYDROBROMIDE).
    Cancer research, 1965, Volume: 25

    Topics: Animals; beta-Aminoethyl Isothiourea; Bone Marrow Transplantation; Gastrointestinal Tract; Guanidine

1965